Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

11.80
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
9.80
Today|||52-Week Range
17.20
-2.88%
Year-to-Date

Today’s Trading

Previous close11.80
Today’s open11.20
Day’s range11.15 - 12.00
Volume1,071,697
Average volume (3 months)478,700
Market cap$635.8M
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-720.15%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratioNM
Price/Sales4.86
Price/Book5.08

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...0.000.00%
FLXNFlexion Therapeutics...0.000.00%
ACRSAclaris Therapeutics...0.000.00%
AKBAAkebia Therapeutics ...0.000.00%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts